Weibo Luo

About Weibo Luo

Weibo Luo, With an exceptional h-index of 39 and a recent h-index of 30 (since 2020), a distinguished researcher at University of Texas Southwestern Medical Center, specializes in the field of Hypoxia, Epigenetics, Metabolism.

His recent articles reflect a diverse array of research interests and contributions to the field:

ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2

Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma

SAP30 promotes breast tumor progression by bridging the transcriptional corepressor SIN3 complex and MLL1

Zinc Finger MYND-Type Containing 8 (ZMYND8) is epigenetically regulated in mutant Isocitrate Dehydrogenase 1 (IDH1) glioma to promote radioresistance

Histone H3 proline 16 hydroxylation regulates mammalian gene expression

GPT2 is induced by hypoxia-inducible factor (HIF)-2 and promotes glioblastoma growth

ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells

Targeting BCAT1 combined with α-ketoglutarate triggers metabolic synthetic lethality in glioblastoma

Weibo Luo Information

University

Position

___

Citations(all)

8609

Citations(since 2020)

4260

Cited By

5962

hIndex(all)

39

hIndex(since 2020)

30

i10Index(all)

55

i10Index(since 2020)

45

Email

University Profile Page

Google Scholar

Weibo Luo Skills & Research Interests

Hypoxia

Epigenetics

Metabolism

Top articles of Weibo Luo

ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2

The Journal of Clinical Investigation

2024/1/23

SAP30 promotes breast tumor progression by bridging the transcriptional corepressor SIN3 complex and MLL1

Journal of Clinical Investigation

2023/9/1

Zinc Finger MYND-Type Containing 8 (ZMYND8) is epigenetically regulated in mutant Isocitrate Dehydrogenase 1 (IDH1) glioma to promote radioresistance

Clinical Cancer Research

2023/5/1

GPT2 is induced by hypoxia-inducible factor (HIF)-2 and promotes glioblastoma growth

Cells

2022/8/20

ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells

Science Advances

2022/7/15

Targeting BCAT1 combined with α-ketoglutarate triggers metabolic synthetic lethality in glioblastoma

Cancer research

2022/7/5

KDM6B promotes PARthanatos via suppression of O6-methylguanine DNA methyltransferase repair and sustained checkpoint response

Nucleic Acids Research

2022/6/24

Emerging role of PARP‐1 and PARthanatos in ischemic stroke

2022/1

AIF3 splicing switch triggers neurodegeneration

Molecular neurodegeneration

2021/12

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

Elife

2021/11/15

MIF is a 3’flap nuclease that facilitates DNA replication and promotes tumor growth

Nature communications

2021/5/19

Lncihat is induced by hypoxia-inducible factor 1 and promotes breast cancer progression

Molecular Cancer Research

2021/4/1

Cutting edge: hypoxia-induced Ubc9 promoter hypermethylation regulates IL-17 expression in ulcerative colitis

The Journal of Immunology

2021/3/1

Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma

Cellular and Molecular Life Sciences

2021/1

ZMYND8 Expression in Breast Cancer Cells Blocks T-Lymphocyte Surveillance to Promote Tumor Growth

Cancer research

2021/1/1

MIF promotes neurodegeneration and cell death via its nuclease activity following traumatic brain injury

Cellular and Molecular Life Sciences

2021/12/18

Multifaceted role of branched-chain amino acid metabolism in cancer

2020/10/29

CHD4 promotes breast cancer progression as a coactivator of hypoxia-inducible factors

Cancer Research

2020/9/15

See List of Professors in Weibo Luo University(University of Texas Southwestern Medical Center)

Co-Authors

academic-engine